Results 51 to 60 of about 255,128 (240)

Family support in treatment of patients diagnosed with schizophrenia: a case report

open access: yesEuropean Psychiatry, 2022
Introduction Schizophrenia is often accompanied by functional deterioration which can impede a person‛s everyday activities. Families are an important part in providing care for their ailed member‚ but often lack resources to deal with different ...
A. Jambrosic Sakoman   +2 more
doaj   +1 more source

Predictive and discriminant validity of different psychopathology and temperament scales for major psychiatric disorders – 23-year follow-up of the Northern Finland Birth Cohort 1966

open access: yesEuropean Psychiatry, 2022
Introduction Several psychological and psychiatric instruments have been developed to recognize or predict different psychiatric disorders. Objectives We studied the predictive, and discriminant validity of different psychopathology scales and ...
J. Miettunen   +2 more
doaj   +1 more source

Eläimet, kasvit ja kulttuurihistoria [PDF]

open access: yes, 2022
Peer ...
Latva, Otto, Lähdesmäki, Heta
core  

Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder

open access: yesEuropean Psychiatry, 2021
Introduction Schizophrenia is highly comorbid with substance use disorders (SUD), which may negatively impact the course of illness. However, large studies exploring the best lines of treatment for this combination are lacking.
M. Lähteenvuo   +6 more
doaj   +1 more source

CX3CL1 in Early Detection of Alzheimer's Disease: Plasma Dynamics Across Age and Disease Stages

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Backgrounds Alzheimer's disease (AD) is characterized by amyloid‐beta plaques, tau tangles, and neuroinflammation. C‐X3‐C motif chemokine ligand 1 (CX3CL1, also known as fractalkine), a neuroimmune chemokine implicated in AD pathogenesis, shows inconsistent alterations in plasma/serum across studies.
Ling Wang   +6 more
wiley   +1 more source

Cognitive Impairment and the correlation with genetic Expression of GAD67, Gad65 and GABA beta2 Using Human Induced Pluripotent Stem Cells

open access: yesEuropean Psychiatry, 2022
Introduction Alteration of GABergic neurotransmission is accused to be sharing in the cognitive impairment in schizophrenia. Exploring the relation between the neuronal expression of GABergic genes and cognitive impairment in living patients through ...
D. Khalifa   +4 more
doaj   +1 more source

Les infirmiers du DUPA aux champs ? [PDF]

open access: yes, 2002
Congrès de l'Union nationale pour la prévention du suicide (UNPS), Paris, février 2002 : Présentation de l'UNPS / Didier Camus - La privation de la relation et l'exclusion.
Matter catherine ... [et al.],
core  

Functional and Structural Evidence of Neurofluid Circuit Aberrations in Huntington Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Disrupted neurofluid regulation may contribute to neurodegeneration in Huntington disease (HD). Because neurofluid pathways influence waste clearance, inflammation, and the distribution of central nervous system (CNS)–delivered therapeutics, understanding their dysfunction is increasingly important as targeted treatments emerge.
Kilian Hett   +8 more
wiley   +1 more source

Estado actual de la investigación: "La invención de nuevos dispositivos: el 'montaje del marco de la escena' en una clínica de la esquizofrenia" [PDF]

open access: yes, 2016
La presente investigación aborda el campo teórico y clínico de la psicosis esquizofrénica a partir del psicoanálisis desarrollado por Sigmund Freud y Jacques Lacan.
Zanchettin, Joceline Fátima
core   +4 more sources

Working memory and abstract thinking in patients with schizophrenic spectrum disorders

open access: yesEuropean Psychiatry, 2021
Introduction According to a selective meta-analytical review, weakness of working memory is considered as one of the fundamental disorders in schizophrenia. Some researchers propose identifying this disorder as an endophenotypic marker of schizophrenia
M. Popov, I. Pluzhnikov
doaj   +1 more source

Home - About - Disclaimer - Privacy